BIOCRYST PHARMACEUTICALS, INC. (BCRX) Gross profit 2016–2025
BIOCRYST PHARMACEUTICALS, INC. (BCRX) annual gross profit history from SEC filings — each fiscal year as reported.
$855.8MFY2025 · since FY2016: $24.1M → $855.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $855.8M | +95.2% |
| FY2024 | $438.4M | +34.1% |
| FY2023 | $326.9M | +23.6% |
| FY2022 | $264.4M | +76.3% |
| FY2021 | $149.9M | +822.0% |
| FY2020 | $16.3M | -63.9% |
| FY2019 | $45.1M | — |
| FY2017 | $24.0M | -0.0% |
| FY2016 | $24.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice